BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benjamin EJ, Al-Khatib SM, Desvigne-Nickens P, Alonso A, Djoussé L, Forman DE, Gillis AM, Hendriks JML, Hills MT, Kirchhof P, Link MS, Marcus GM, Mehra R, Murray KT, Parkash R, Piña IL, Redline S, Rienstra M, Sanders P, Somers VK, Van Wagoner DR, Wang PJ, Cooper LS, Go AS. Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report. J Am Heart Assoc 2021;:e021566. [PMID: 34351783 DOI: 10.1161/JAHA.121.021566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Hendriks JM, Elliott AD, Middeldorp ME, Sanders P. Contributing factors to personalised medicine in atrial fibrillation. Heart 2023;109:164-5. [PMID: 36175112 DOI: 10.1136/heartjnl-2022-321553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Benjamin EJ, Thomas KL, Go AS, Desvigne-nickens P, Albert CM, Alonso A, Chamberlain AM, Essien UR, Hernandez I, Hills MT, Kershaw KN, Levy PD, Magnani JW, Matlock DD, O’brien EC, Rodriguez CJ, Russo AM, Soliman EZ, Cooper LS, Al-khatib SM. Transforming Atrial Fibrillation Research to Integrate Social Determinants of Health. JAMA Cardiol 2022. [DOI: 10.1001/jamacardio.2022.4091] [Reference Citation Analysis]
3 Kornej J, Qadan MA, Alotaibi M, Van Wagoner DR, Watrous JD, Trinquart L, Preis SR, Ko D, Jain M, Benjamin EJ, Cheng S, Lin H. The association between eicosanoids and incident atrial fibrillation in the Framingham Heart Study. Sci Rep 2022;12:20218. [PMID: 36418854 DOI: 10.1038/s41598-022-21786-0] [Reference Citation Analysis]
4 Gonçalves-Teixeira P, Costa T, Fragoso I, Ferreira D, Brandão M, Leite-Moreira A, Sampaio F, Ribeiro J, Fontes-Carvalho R. Screening, Diagnosis and Management of Atrial Fibrillation in Cancer Patients: Current Evidence and Future Perspectives. Arq Bras Cardiol 2022;119:328-41. [PMID: 35946695 DOI: 10.36660/abc.20201362] [Reference Citation Analysis]
5 Linz B, Hertel JN, Jespersen T, Linz D. Mechanisms and therapeutic opportunities in atrial fibrillation in relationship to alcohol use and abuse. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Govindapillai A, Cox JL, Thabane L, Doucette S, Xie F, Mackillop JH, Ciaccia A, Choudhri SH, Nemis-white JM, Hamilton LM, Parkash R. Rhythm control versus rate control in a contemporary ambulatory atrial fibrillation cohort: Post-hoc analysis of the IMPACT-AF Trial. CJC Open 2022. [DOI: 10.1016/j.cjco.2022.03.001] [Reference Citation Analysis]
7 O’reilly M, Sommerfeld L, O’shea C, Broadway-stringer S, Andaleeb S, Reyat J, Kabir S, Stastny D, Malinova A, Delbue D, Fortmueller L, Gehmlich K, Pavlovic D, Skryabin B, Holmes A, Kirchhof P, Fabritz L. Increased early sodium current causes familial atrial fibrillation and dampens effect of flecainide.. [DOI: 10.1101/2022.01.18.476646] [Reference Citation Analysis]
8 Marcus GM, Modrow MF, Schmid CH, Sigona K, Nah G, Yang J, Chu TC, Joyce S, Gettabecha S, Ogomori K, Yang V, Butcher X, Hills MT, McCall D, Sciarappa K, Sim I, Pletcher MJ, Olgin JE. Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation: The I-STOP-AFib Randomized Clinical Trial. JAMA Cardiol 2021. [PMID: 34775507 DOI: 10.1001/jamacardio.2021.5010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]